Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |